Oleic acid increases intestinal absorption of the BCRP/ABCG2 substrate, mitoxantrone, in mice

被引:7
作者
Aspenstrom-Fagerlund, Bitte [1 ]
Tallkvist, Jonas [2 ]
Ilback, Nils-Gunnar [1 ,3 ]
Glynn, Anders W. [1 ,4 ]
机构
[1] Natl Food Agcy, Risk & Benefit Assessment Dept, SE-75126 Uppsala, Sweden
[2] Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, SE-75007 Uppsala, Sweden
[3] Uppsala Univ, Infect Dis Sect, Dept Med Sci, SE-75185 Uppsala, Sweden
[4] Uppsala Univ, Dept Environm Toxicol, SE-75236 Uppsala, Sweden
关键词
Oleic acid; BCRP; Mitoxantrone; FVB mice; Intestinal absorption; CANCER RESISTANCE PROTEIN; CACO-2; CELLS; NUCLEAR RECEPTORS; DRUG ABSORPTION; FATTY-ACIDS; TRANSPORTER; EFFLUX; INHIBITION; EXPRESSION; PHARMACOKINETICS;
D O I
10.1016/j.toxlet.2015.06.009
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The efflux transporter breast cancer resistance protein (BCRP/ABCG2) decrease intestinal absorption of many food toxicants. Oleic acid increases absorption of the specific BCRP substrate mitoxantrone (MXR), and also BCRP gene expression in human intestinal Caco-2 cells, suggesting that oleic acid affect the BCRP function. Here, we investigated the effect of oleic acid on intestinal absorption of MXR in mice. Mice were orally dosed with 2.4 g oleic acid/kg b.w. and 1 mg MXR/kg b.w., and sacrificed 30, 60, 90 or 120 min after exposure, or were exposed to 0.6, 2.4 or 4.8 g oleic acid/kg b.w. and 1mg MXR/kg b.w., and sacrificed 90 min after exposure. Mice were also treated with Ko143 together with MXR and sacrificed after 60 min, as a positive control of BCRP-mediated effects on MXR absorption. Absorption of MXR increased after exposure to oleic acid at all doses, and also after exposure to Ko143. Intestinal BCRP gene expression tended to increase 120 min after oleic acid exposure. Our results in mice demonstrate that oleic acid decreases BCRP-mediated efflux, causing increased intestinal MXR absorption in mice. These findings may have implications in humans, concomitantly exposed to oleic acid and food contaminants that, similarly as MXR, are substrates of BCRP. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:133 / 139
页数:7
相关论文
共 50 条
  • [1] Oleic acid decreases BCRP mediated efflux of mitoxantrone in Caco-2 cell monolayers
    Aspenstrom-Fagerlund, Bitte
    Tallkvist, Jonas
    Ilback, Nils-Gunnar
    Glynn, Anders W.
    FOOD AND CHEMICAL TOXICOLOGY, 2012, 50 (10) : 3635 - 3645
  • [2] Design of inhibitors of BCRP/ABCG2
    Juvale, Kapil
    Wiese, Michael
    FUTURE MEDICINAL CHEMISTRY, 2015, 7 (12) : 1521 - 1527
  • [3] Differential inhibition of murine Bcrpl/Abcg2 and human BCRP/ABCG2 by the mycotoxin fumitremorgin C
    Gonzalez-Lobato, Lucia
    Real, Rebeca
    Prieto, Julio G.
    Alvarez, Ana I.
    Merino, Gracia
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 644 (1-3) : 41 - 48
  • [4] Folate deprivation induces BCRP (ABCG2) expression and mitoxantrone resistance in Caco-2 cells
    Lemos, Clara
    Kathmann, Ietje
    Giovannetti, Elisa
    Dekker, Henk
    Scheffer, George L.
    Calhau, Conceicao
    Jansen, Gerrit
    Peters, Godefridus J.
    INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (07) : 1712 - 1720
  • [5] Interactions between riluzole and ABCG2/BCRP transporter
    Milane, Aline
    Vautier, Sarah
    Chacun, Helene
    Meininger, Vincent
    Bensimon, Gilbert
    Farinotti, Robert
    Fernandez, Christine
    NEUROSCIENCE LETTERS, 2009, 452 (01) : 12 - 16
  • [6] Tariquidar-related triazoles as potent, selective and stable inhibitors of ABCG2 (BCRP)
    Antoni, Frauke
    Bause, Manuel
    Scholler, Matthias
    Bauer, Stefanie
    Stark, Simone A.
    Jackson, Scott M.
    Manolaridis, Ioannis
    Locher, Kaspar P.
    Koenig, Burkhard
    Buschauer, Armin
    Bernhardt, Guenther
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 191
  • [7] Physiological and pharmacological roles of ABCG2 (BCRP): Recent findings in Abcg2 knockout mice
    Vlaming, Maria L. H.
    Lagas, Jurjen S.
    Schinkel, Alfred H.
    ADVANCED DRUG DELIVERY REVIEWS, 2009, 61 (01) : 14 - 25
  • [8] Down-regulation of the placental BCRP/ABCG2 transporter in response to hypoxia signaling
    Francois, Lissa N.
    Gorczyca, Ludwik
    Du, Jianyao
    Bircsak, Kristin M.
    Yen, Elizabeth
    Wen, Xia
    Tu, Mei-Juan
    Yu, Ai-Ming
    Illsley, Nicholas P.
    Zamudio, Stacy
    Aleksunes, Lauren M.
    PLACENTA, 2017, 51 : 57 - 63
  • [9] Modulation of Intestinal Transport and Absorption of Topotecan, a BCRP Substrate, by Various Pharmaceutical Excipients and Their Inhibitory Mechanisms of BCRP Transporter
    Sawangrat, Kasirawat
    Yamashita, Shugo
    Tanaka, Akiko
    Morishita, Masaki
    Kusamori, Kosuke
    Katsumi, Hidemasa
    Sakane, Toshiyasu
    Yamamoto, Akira
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 108 (03) : 1315 - 1325
  • [10] Breast cancer resistance protein BCRP (ABCG2)-mediated transepithelial nitrofurantoin secretion and its regulation in human intestinal epithelial (Caco-2) layers
    Wright, Jamie A.
    Haslam, Lain S.
    Coleman, Tanya
    Simmons, Nicholas L.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2011, 672 (1-3) : 70 - 76